Researchers Identify Biomarker for Glaucoma Damage
Today, RPB-supported researchers at Washington University School of Medicine in St. Louis published a study identifying a biomarker that could help to predict glaucoma damage before vision loss.
An optic nerve with glaucoma damage, signified by loss of color and a round rim of pink tissue within the nerve.
Photo credit: CARLA J. SIEGFRIED / Washington University School of Medicine in St. Louis
"There hasn't been a reliable way to predict which patients with glaucoma have a high risk of rapid vision loss," said principal investigator Rajendra S. Apte, MD, PhD, the Paul A. Cibis Distinguished Professor of Ophthalmology and Visual Sciences.
"But we've identified a biomarker that seems to correlate with disease severity in patients, and what that marker is measuring is stress to the cells rather than cell death. Other glaucoma tests are measuring cell death, which is not reversible, but if we can identify when cells are under stress, then there's the potential to save those cells to preserve vision," said Dr. Apte.
May 4, 2017
Related News: Feature Story, Glaucoma, Top Story
An RPB Awardee Tackles Inherited Retinal Diseases
Dr. Krzysztof Palczewski develops and applies cutting-edge gene editing techniques to challenging genetic conditions.
RPB and Association of University Professors of Ophthalmology Announce 2023 Recipient of RPB David F. Weeks Award for Outstanding Vision Research
David J. Calkins, PhD, is recognized for ground-breaking contributions to the field of vision research.
Research to Prevent Blindness and the American Academy of Ophthalmology Award New Research Grants to Improve Eye Care
Award recipients to use the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) clinical database to improve care for all patients.
Grant from Research to Prevent Blindness and Castle Biosciences Supports Medical Student Research in Ocular Cancer
Research to Prevent Blindness and Castle Biosciences are partnering to provide new opportunities for medical students to pursue ocular cancer research.
New Glaucoma Research Grant Available
Research to Prevent Blindness and Aerie Pharmaceuticals are partnering to provide grant opportunities to support novel research in glaucoma.
New Vision Science Research Grant for Students of Osteopathic Medicine
RPB and the AOCOO-HNS Foundation are launching a multi-year partnership to provide funding to increase research opportunities in vision science for students of osteopathic medicine.
Subscribe
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
| General Info | Grants | News & Resources |
Research to Prevent Blindness
360 Lexington Avenue, 22nd Floor
New York, NY 10017
(212) 752-4333
Copyright © 2022 Research to Prevent Blindness. All Rights Reserved.
